InvestorsHub Logo
Followers 26
Posts 1154
Boards Moderated 0
Alias Born 02/09/2021

Re: docsetc post# 197328

Wednesday, 04/24/2024 3:56:35 PM

Wednesday, April 24, 2024 3:56:35 PM

Post# of 198996
Just because we don't know any different at this time, there may be another reason they've split from ENZC: In short, the work's done, rewards are on the way via a pending deal on their IP and it's time to retire (or go it alone) and let ENZC (or SAGA if still alive) have the deal on those 3 patents. They get their royalties and have stock in both companies (assuming SAGA survives). There was probably an absence of cohesiveness between them and Harry anyway. JMHO.

ENZC hasn't said anything about the Cotropia's yet, only that ENZC wanted Chandra as their CEO, and that he didn't want it. The Cotropia's and Chandra either have something with their IP or they've got nothing. Based on the information you gathered, which I greatly appreciate, I think it bolsters the argument that they're on to something and have made a strong effort to research and patent their results. Has it failed in the end? Don't know. The suddenness of the move without any comments is disturbing. JMHO.

I'm wondering if the Cotropias' actions could be an indication that they know there's already a deal on the table that will commercialize those 3 patents when granted. They assigned those patent applications to Biogenysis in 2022 and 2023 and will receive a 15% royalty (5% each) on each patent. IMO, that is a substantial royalty. It's been very curious/suspicious to me why they've been very quiet about them (and additional research) for a year or so. They have also made recent amendments to the patent applications with comments that they believe those amendments answer all examiner issues. That is public information. They've either got something and it's close to paying off or they can't work with Harry any longer or they've got nothing. JMHO.

So, maybe they believe the patents will be granted and a pending deal IF THERE IS ONE, which should be between Biogenysis and a 3rd party, will be executed and that's enough for them to walk away and do something else. If this is the case, they could also continue with research and cut a deal with Harry (or a 3rd party) for more royalties on new patent applications or do contract research. JMHO.

Like everybody else, I want some thorough, honest information and explanations from ENZC, SAGA and the Cotropia's. They owe it to us.